Implications of a Circulating Vaccine-Derived Poliovirus in Nigeria
- 24 June 2010
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 362 (25), 2360-2369
- https://doi.org/10.1056/nejmoa0910074
Abstract
The largest recorded outbreak of a circulating vaccine-derived poliovirus (cVDPV), detected in Nigeria, provides a unique opportunity to analyze the pathogenicity of the virus, the clinical severity of the disease, and the effectiveness of control measures for cVDPVs as compared with wild-type poliovirus (WPV).This publication has 15 references indexed in Scilit:
- Estimating the Extent of Vaccine-Derived Poliovirus InfectionPLOS ONE, 2008
- Effectiveness of Immunization against Paralytic Poliomyelitis in NigeriaNew England Journal of Medicine, 2008
- Monovalent Type 1 Oral Poliovirus Vaccine in NewbornsNew England Journal of Medicine, 2008
- Vaccination against polio should not be stoppedNature Reviews Microbiology, 2007
- Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control studyThe Lancet, 2007
- Vaccine-derived poliovirusesBiologicals, 2006
- Is Polio Eradication Realistic?Science, 2006
- Circulation of Endemic Type 2 Vaccine-Derived Poliovirus in Egypt from 1983 to 1993Journal of Virology, 2003
- Sabin Monovalent Oral Polio Vaccines: Review of Past Experiences and Their Potential Use after Polio EradicationClinical Infectious Diseases, 2001
- Differential Diagnosis of Acute Flaccid Paralysis and its Role in Poliomyelitis SurveillanceEpidemiologic Reviews, 2000